271 related articles for article (PubMed ID: 21703999)
1. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
Velin D; Favre L; Bernasconi E; Bachmann D; Pythoud C; Saiji E; Bouzourene H; Michetti P
Gastroenterology; 2009 Jun; 136(7):2237-2246.e1. PubMed ID: 19272385
[TBL] [Abstract][Full Text] [Related]
4. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
Lucas B; Bumann D; Walduck A; Koesling J; Develioglu L; Meyer TF; Aebischer T
Infect Immun; 2001 Mar; 69(3):1714-21. PubMed ID: 11179348
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant.
Hitzler I; Oertli M; Becher B; Agger EM; Müller A
Gastroenterology; 2011 Jul; 141(1):186-96, 196.e1. PubMed ID: 21569773
[TBL] [Abstract][Full Text] [Related]
7. Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1β and IL-18.
Hitzler I; Sayi A; Kohler E; Engler DB; Koch KN; Hardt WD; Müller A
J Immunol; 2012 Apr; 188(8):3594-602. PubMed ID: 22403439
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
9. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori.
Wee JL; Chionh YT; Ng GZ; Harbour SN; Allison C; Pagel CN; Mackie EJ; Mitchell HM; Ferrero RL; Sutton P
Gastroenterology; 2010 Feb; 138(2):573-82. PubMed ID: 19706295
[TBL] [Abstract][Full Text] [Related]
11. Vaccinating against Helicobacter pylori: dissecting the mechanism.
Sutton P
Gastroenterology; 2011 Oct; 141(4):1149-51. PubMed ID: 21872593
[No Abstract] [Full Text] [Related]
12. Helicobacter infection in the surfactant protein D-deficient mouse.
Khamri W; Worku ML; Anderson AE; Walker MM; Hawgood S; Reid KB; Clark HW; Thursz MR
Helicobacter; 2007 Apr; 12(2):112-23. PubMed ID: 17309747
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis.
Oertli M; Engler DB; Kohler E; Koch M; Meyer TF; Müller A
J Immunol; 2011 Oct; 187(7):3578-86. PubMed ID: 21880981
[TBL] [Abstract][Full Text] [Related]
14. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
Harbour SN; Mitchell HM; Sutton P
Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
[TBL] [Abstract][Full Text] [Related]
15. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.
Gottwein JM; Blanchard TG; Targoni OS; Eisenberg JC; Zagorski BM; Redline RW; Nedrud JG; Tary-Lehmann M; Lehmann PV; Czinn SJ
J Infect Dis; 2001 Aug; 184(3):308-14. PubMed ID: 11443556
[TBL] [Abstract][Full Text] [Related]
16. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
17. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions.
Voland P; Zeitner M; Hafsi N; Prinz C
Vaccine; 2006 May; 24(18):3832-9. PubMed ID: 16122847
[TBL] [Abstract][Full Text] [Related]
18. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model.
Velin D; Bachmann D; Bouzourene H; Michetti P
Gastroenterology; 2005 Jul; 129(1):142-55. PubMed ID: 16012944
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
